Pacira BioSciences (PCRX) Other financing activities (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Other financing activities of $2000.0 for Q1 2026, down 99.59% quarter-over-quarter from $490000.0 in Q4 2025.
Pacira BioSciences (PCRX) Other financing activities (2010 - 2026) Analysis & Trends
Pacira BioSciences' Other financing activities history runs 16 years deep, the most recent figure standing at $2000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $2000.0; the TTM figure through Mar 2026 stood at $492000.0 (changed N/A YoY), while the FY2025 annual figure was $502000.0, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $2000.0, down from $490000.0 in the prior quarter.
- The five-year high for Other financing activities was $11.0 million in Q1 2022, with the low at $2000.0 in Q1 2026.
- The 4-year median for Other financing activities is $905000.0 (2022), against an average of $3.0 million.
- The sharpest annual moves came in 2022 and 2023: Other financing activities jumped 91.41% in 2022, then slumped 98.38% in 2023.
- Pacira BioSciences' Other financing activities stood at $905000.0 in 2022, then plunged by 97.13% to $26000.0 in 2023, then jumped by 1784.62% to $490000.0 in 2025, then tumbled by 99.59% to $2000.0 in 2026.
- Business Quant data shows PCRX's Other financing activities at $2000.0 in Q1 2026, $490000.0 in Q4 2025, and $26000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457,000.00 |
| Jun 30, 2026 | 457,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 490,000.00 |
| Dec 31, 2025 | 490,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 333,000.00 |
| Mar 31, 2023 | 333,000.00 |
| Dec 31, 2022 | 905,000.00 |
| Dec 31, 2022 | 905,000.00 |
| Sep 30, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 10.86 Mn |
| Jun 30, 2022 | 10.86 Mn |
| Mar 31, 2022 | 11.02 Mn |
| Mar 31, 2022 | 11.02 Mn |